Current Status 

Currently raising capital to fund a pivotal 150 patient study planned for 2nd quarter of 2016.  Submitting applications to begin developing strategic partnerships with leading pharma companies.

 

Milestones and catalysts​

Intellectual Property: Patents issued in 2002, 2004, 2007  

Regulatory: Blue Letters releasing trials under EMA rules issued March 2016. Expecting to File US IND based on these studies in the 2nd quarter of 2017

​​

​